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Abstract The purpose of this study is to evaluate
pattern electroretinogram optimized for glaucoma
screening (PERGLA) and retinal nerve fiber layer
(RNFL) at spectral optical coherence tomography
(OCT) in eyes with suspected glaucoma (GS) and in
eyes with ocular hypertension (OHT). This is a cross-
sectional, observational study. Twenty-four patients
with GS (BCVA 20/20, normal visual field, intraoc-
ular pressure, IOP, less than 21 mmHg, and glauco-
matous optic neuropathy, GON) and 14 patients with
OHT (BCVA 20/20, intraocular pressure 25 mmHg,
absence of glaucomatous optic neuropathy and nor-
mal visual field) were considered in this study. GON
was intended as vertical cup-disk ratio of 0.5 or more;
asymmetry of greater than 0.2, disk notching, disk
splinter hemorrhages. PERGLA amplitude and phase
were measured, while thickness of the RNFL was
obtained with spectral OCT. A control group of 50
age-matched healthy patients was added. In the GS
group, 16 eyes (66.7%) showed normal average
RNFL analysis and normal PERGLA, 3 eyes (12.5%)
showed abnormal average RNFL analysis and abnor-
mal PERGLA, 5 eyes (20.8%) presented with normal
average RNFL analysis and abnormal PERGLA. In
the OHT group, 11 eyes (78.6%) showed an average
normal RNFL and normal PERGLA, while 3 eyes
(21.4%) presented with an average normal RNFL and
abnormal PERGLA. PERGLA is a non-invasive, fast,
and fully automatic version of the pattern ERG. In eyes
with OHT and in eyes with GS, PERGLA abnormalities
in presence of a normal RNFL could suggest an early
functional damage of viable retinal ganglion cells.
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Introduction
Glaucoma is an optic neuropathy characterized by
progressive loss of retinal ganglion cells (RGCs) and
their axons, changes in optic disc topography, and
associated deficits of visual function. The pattern
electroretinogram (PERG) is an indicator of retina
ganglion cell function in primates [1, 2]. Glaucoma or
high-risk ocular hypertension will affect the ampli-
tude of the P1 and N2 components of the transient
PERG, as well as the amplitude of the steady state
PERG [3]. Retinal nerve fiber layer (RNFL) thick-
ness, determined by optical coherence tomography
(OCT), reduces in glaucoma suspects and in early
glaucoma [4–6]. In ocular hypertension, an abnormal
amplitude of N2 wave has been reported at PERG
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examination [7], and a correlation between PERG
changes and RNFL thickness has been shown [8]. In
early glaucoma, the amount of PERG loss is substan-
tially greater than predicted by RNFL thickness loss
[9]. This could suggest an early stage of the disease
(pre-perimetric glaucoma) where RGC dysfunction
may precede cellular and axonal numerical loss.
A simplified version of the PERG for screening and
follow up of glaucoma (PERGLA) has been recently
introduced [10]. Preliminary studies suggest that
PERG measurements using this technique are repeat-
able and as reliable as the traditional protocols [11–13].
In this study, we evaluated PERGLA and RNFL
thickness in eyes with glaucomatous optic neuropathy
(suspected glaucoma) and in eyes with increased
intraocular pressure.
Methods
In this cross-sectional, observational study, we con-
sidered all patients presenting with ocular hyperten-
sion and all patients presenting with suspected
glaucoma (glaucomatous optic neuropathy in absence
of increased intraocular pressure, IOP and visual field
defects), visited in the ocular electrophysiology
department of the University Federico II from March
2006 to June 2007. An age-matched control group of
50 patients (25 males and 25 females, 50 eyes) was
used. All patients underwent best-corrected visual
acuity (BCVA) examination, refraction at distance
and near, IOP measurement with Goldmann appla-
nation tonometry, corneal pachymetry, gonioscopy,
dilated fundus examination, stereophotographs of the
optic disc. Patients with ocular hypertension and with
suspected glaucoma underwent a Humphrey perim-
eter central 24-2 program. Vertical cup-to-disc (C/D)
ratios were evaluated from stereo photographs of the
optic disc by an independent observer (RF).
Suspected glaucoma (GS) group presented with a
BCVA C 20/20, a normal visual field according to the
Ocular Hypertension Treatment Study (OHTS) criteria
[14] (reliability \ 33% on all indices, normality [ 5%
on all global indices in two consecutive sessions
6 months apart), IOP less than 21 mmHg (measured
with Goldmann applanation tonometry at two different
times) and glaucomatous optic neuropathy (GON)
(vertical cup-disk ratio of 0.5 or more; asymmetry C0.2,
disk notching, disk splinter hemorrhages).
Ocular hypertension (OHT) groups presented with
a BCVA C 20/20, an intraocular pressure reading
equal to or greater than 25 mmHg on at least two
separate occasions in absence of glaucomatous optic
neuropathy and in presence of a normal visual field.
Patients in the control group were free from
systemic or ocular diseases as assessed by routine
ophthalmologic examination, had BCVA of 20/20 or
better, an intraocular pressure \21 mmHg, normal
optic nerve head and an age-range similar to the study
groups.
The reasons for exclusion included an age \22 years,
a history of any disease, surgery, or trauma in the eye
being tested; a history of systemic medication use that
might affect the visual field or retina; peripapillary
atrophy; association with PERG-influencing ocular and
systemic diseases (diabetes, age-related macular degen-
eration, optic neuropathy, retinitis pigmentosa, Best
disease, Stargardt disease, multiple sclerosis, Parkinson
disease); unreliable visual fields (fixation losses [33%,
false-positiveresponses[33%,orfalse-negativeresponses
[33%); BCVA \20/20; refractive defects greater that
3.5 diopters; treatment with antiglaucomatous medi-
caments; treatment with vasoactive neurological med-
icaments. The study adhered to the tenets of the
Declaration of Helsinki. All participants gave their
informed consent.
PERGLA technique
PERGLA was recorded using a commercial device
called ‘‘Glaid’’ (Lace Elettronica, Pisa, Italy), as
described by Porciatti and Ventura [10]. To obtain
PERGLA, standard 9-mm silver chloride cup elec-
trodes were taped on the central forehead, on the
temples and lower eyelids. The pattern stimulus
consisted of a black–white horizontal bar grating
(1.7 cyc/deg, 25 circular field, 95% contrast, 40 cd/m2
mean luminance), reversed in counterphase at
8.14 Hz (16.28 reversals/s). The subject was optically
corrected for viewing distance (30 cm) and fixated
with undilated pupils on a target at the center of the
stimulus. Electrical signal was amplified (100,000-
fold), filtered (1–30 Hz) and digitized with 12-bit
resolution at 4,169 Hz. The PERGLA waveform was
obtained by averaging 600 artifact-free time periods
of 122.8 ms in duration. Two independent response
blocks of 330 sweeps each were recorded. The
response was typically steady state with a sinusoidal
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like waveform. Steady state responses were analyzed
best in the frequency domain by digital Fourier
transform to isolate the harmonic component at the
contrast reversal rate and to compute its amplitude in
lV and phase in p rad. In addition, a noise response was
obtained by multiplying alternate sweeps by 1 and -1
before averaging. The noise response also was Fourier
transformed at 16.28 Hz to allow calculation of signal-
to-noise ratio. The procedure took approximately
4 min. Resulting response amplitudes and latencies
were recorded as independent study variables. These
values were compared with results from the control
group (measured in the same conditions) to classify
individuals as within or outside of normal limits.
PERGLA examinations were considered outside of
normal limits if the amplitude (either eye), phase
(either eye), interocular amplitude asymmetry or phase
asymmetry was outside of normal limits (defined as
outside two standard deviations of normal variability,
depressed or retarded for amplitude and phase, respec-
tively) on two consecutive tests.
OCT technique
To obtain RNFL analysis, a spectral domain OCT
(SD-SLO/OCT, Ophthalmic Technologies Inc., OTI,
Toronto, Canada) was used. SD-SLO/OCT acquires
128 longitudinal B scans (27000 A-scans per second
with an axial resolution of five microns) in 2 s over a
5 mm area. For analysis, SD-SLO/OCT algorithms
identify the center of the optic disc and automatically
place a calculation circle of 3.46 mm diameter
around it. The anterior and posterior margins of the
RNFL are delineated and the system calculates the
RNFL thickness along a 3.46 mm ring. Three con-
secutive optic disk scans were acquired and analyzed
for each eye. RNFL measurements were averaged
using data from each of the three scans.
PERGLA-matched temporal RNFL thickness was
defined as the RNFL thickness of the temporal sector
corresponding to 60 above and 75 below the
horizontal axis can, which corresponds to the area
where axons of RGCs recruited by the PERG
stimulus are expected to enter the disc [9].
Statistics
For each patient, only one eye (the right eye) was
included in the analysis. Statistical analysis was
performed using the Statistical Package for Social
Sciences (version 17.0, SPSS Inc., Chicago, IL, USA).
The correlation between PERGLA amplitude, PER-
GLA phase and RNFL thickness was calculated with
Pearson Test. The correlation between PERG ampli-
tude and disc cupping was calculated by Spearman rho.
Results
Thirty-eight eyes (38 patients, 14 males, 24 females
with a mean age of 45.7 ± 12.7 years) were included
in the study. Clinical and demographic characteristics
of the study population are summarized in Table 1.
Patients in the control group had a mean age of
45.3 ± 12.3 years. In the suspected glaucoma group,
there were 24 eyes (24 patients, 9 males and 15 females
with a mean age of 46.4 ± 14.5 years). The mean IOP
of GS eyes was 17.2 ± 2.2 mmHg. Among them, 16
eyes (66.7%) showed normal average RNFL analysis
and normal PERGLA, 3 eyes (12.5%) showed abnor-
mal average RNFL analysis and abnormal PERGLA, 5
eyes (20.8%) presented with normal average RNFL
analysis and abnormal PERGLA. In no case was there
coexistence of abnormal average RNFL and normal
PERGLA (Table 2).
In the OHT group, there were 14 eyes (14 patients, 5
females and 9 males with a mean age of 44.5 ±
9.3 years). The mean IOP of OHT eyes was 26.8 ±
1.8 mmHg. Among them, 11 eyes (78.6%) showed an
average normal RNFL and normal PERGLA, while 3
eyes (21.4%) presented with an average normal RNFL
and abnormal PERGLA. In no case, there was asso-
ciation between average abnormal RNFL and normal
PERGLA, and between average abnormal RNFL and
abnormal PERGLA.
Pearson correlation between PERGLA amplitude
and RNFL thickness was 0.44 (P = 0.1) in OHT
group and 0.54 (P = 0.2) in the GS group (Fig. 1).
Pearson correlation between PERGLA phase and
RNFL thickness was 0.40 (P = 0.2) in the OHT
group and 0.52 (P = 0.08) in the GS group (Fig. 2).
Low correlation was found between PERGLA ampli-
tude losses and the amount of cupping (r = 0.2,
P = 0.03).
As concerns PERGLA-matched temporal sector,
the number of GS found abnormal by PERGLA and
not OCT was higher than the number found by OCT
and not PERGLA (4 vs. 0, respectively, P = 0.2, Chi
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square test). Also in the OHT group, the number of
eyes found abnormal by PERGLA and not OCT was
higher than the number found abnormal by OCT and
not PERGLA (2 vs. 0, P = 0.3).
Discussion
This study evaluated both PERGLA and RNFL in eyes
with OHT and glaucoma suspects. Previous studies
have evaluated these changes with standard PERG in
eyes with suspected glaucoma and early manifest
glaucoma [9, 15], in eyes with OHT only [8, 16], and
in eyes with OHT and early glaucoma [17]. PERGLA
is a non-invasive, fast and fully automatic version of
the pattern ERG and has been primarily used as a well
standardized paradigm of the standard PERG for early
detection and follow up of glaucoma patients [10–13].
In PERGLA, only skin electrodes are used, which
avoids contact with the cornea. The PERGLA uses
optimized stimulus parameters for boosting the signal-
to-noise ratio, and although PERGLA amplitude is
about three times lower than PERG, the intrusions
from eye movements are also lower.
In the suspected glaucoma group, there was
concordance between the two techniques in 79.2%
of cases; in 20.8% of cases there was no concordance,
and they all presented with a normal average RNFL
analysis and abnormal PERGLA. In the OHT group,
there was concordance in 78.6% of cases; in 21.4% of
cases there was no concordance, and they all
presented with an average normal RNFL analysis
and abnormal PERGLA. A positive correlation was
found in both groups between average RNFL thick-
ness and PERGLA amplitude and phase. In glaucoma
suspects and in ocular hypertension, the PERG
examination may indicate presence of a functional
damage before evidence of a structural damage,
therefore providing an earlier diagnosis of glaucoma
when compared to OCT [5, 16–19]. PERG amplitude
has shown to increase after IOP-lowering treatment
[20], and detection of electrophysiological damage
Table 1 Clinical and
diagnostic characteristics
in GS and OHT groups
GS glaucoma suspect,
OHT ocular hypertension,
IOP intraocular pressure,
PERG pattern
electroretinogram, RNFL
average retinal nerve fiber
layer thickness
Control group GS OHT
n 50 24 14
Sex 25F/25 M 15F/9 M 5F/9 M
IOP (mmHg) 16.2 ± 1.8 17.2 ± 2.2 23.8 ± 1.8
PERG amplitude (lV) 1.11 ± 0.11 0.59 ± 0.24 0.92 ± 0.29
PERG SD amplitude (lV) -0.08 ± 0.8 -1.94 ± 1.52 -0.82 ± 0.98
PERG phase (p radians) 1.83 ± 0.10 1.60 ± 0.18 1.76 ± 0.08
PERG SD phase (p radians) -0.58 ± 1.01 -3.15 ± 2.42 -1.34 ± 0.82
RNFL (lm) 115.2 ± 11.2 90.12 ± 20.74 114.41 ± 13.93
Table 2 Number of normal and abnormal measures for PERG
amplitude and average RNFL thickness
RNFL normal RNFL abnormal
GS
PERG normal 16 (66.7%) 0
PERG abnormal 5 (20.8%) 3 (12.5%)
OHT
PERG normal 11 (78.6%) 0
PERG abnormal 3 (21.4%) 0
PERG pattern electroretinogram, RNFL average retinal nerve
fiber layer thickness
Fig. 1 Graph showing the correlation between PERG ampli-
tude and average RNFL thickness among 38 eyes with ocular
hypertension (OHT) or sole glaucomatous optic neuropathy
(GS) (PERG pattern electroretinogram, RNFL retinal nerve
fiber layer thickness)
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with PERGLA in eyes with sole increase of IOP or
sole GON could suggest the need for an antiglauco-
matous treatment.
Sector analysis of the RNFL thickness (PERGLA-
matched temporal sector), also showed more
PERGLA abnormalities than RNFL thickness abnor-
malities. PERG may present a high rate of false
positives [16] and as PERG reflects diffuse, non-
focal, damage to the ganglion cells [19], it may fail in
recognition of focal RNFL defects. As the initial
glaucomatous changes begin with local loss of RGCs
and their axons, early loss of RGC axons affects the
PERG matched temporal sector [9].
The PERGLA amplitude is negatively correlated
with IOP and age in healthy eyes. Although in our
study we used a control group of normal age-matched
healthy eyes, in PERGLA, data are referred to a
normative database for subjects aged 12–85
(43.8 ± 18.0) years [10]. Previous studies have
shown a lower PERGLA specificity when older
population was investigated [13]. As mean age in
our series was similar to the mean age used for the
normative database, specificity and sensibility of
PERGLA in our study were supposed to be as least as
good as PERG.
A limit of this study is the relatively small size of
the two study groups. Reproducibility and reliability
of PERGLA when compared to standard PERG have
already been reported [10–13], and although on a
small series our results suggest that PERGLA could
likely represent a fast and easy alternative to PERG in
evaluating early damage in ocular hypertension and
glaucoma suspect. Another limit of this study is its
cross-sectional design. However, in both cross-sec-
tional and longitudinal studies with greater popula-
tion, the PERG amplitude has shown signs of
glaucomatous damage earlier than psychometric and
morphologic techniques in manifest or suspected
glaucoma [21–28]. In longitudinal studies, PERG
predicted stability or progression of OHT to manifest
glaucoma at least one year before conversion with a
sensitivity and specificity of [70% [16].
In conclusion, our results suggest a possible role of
PERGLA as a non-invasive, easy means to evaluate
early RGCs damage in ocular hypertension and
glaucoma suspect. Prospective studies with a larger
population are planned to evaluate the incidence of
conversion to glaucoma in both groups.
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